New seizure drug tested in ICU for rapid control
NCT ID NCT06352723
First seen Apr 17, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This study tests a drug called cenobamate to quickly stop frequent seizures or ongoing seizure emergencies (status epilepticus) in intensive care patients. Ten adults aged 18-70 who have many seizures per hour will receive the drug while being closely monitored. The main goals are to see if the drug reaches a target level in the blood and helps stop seizures within 24 hours. Safety checks will watch for a rare but serious allergic reaction called DRESS syndrome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.